# Christopher D. Lao

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/christopher-d-lao/

## Facts

| Field | Value |
| --- | --- |
| Citations | 38,104 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 57 |
| i10-index | 106 |
| Last Known Institution | University of Michigan |
| OpenAlex ID | https://openalex.org/A5108566653 |
| Works | 179 |

## Researcher papers

- [Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial](https://scholariq.org/papers/nivolumab-versus-chemotherapy-in-patients-with-advanced-melanoma-who-progressed/)
- [Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma](https://scholariq.org/papers/neoadjuvant-adjuvant-or-adjuvant-only-pembrolizumab-in-advanced-melanoma/)
- [Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression](https://scholariq.org/papers/host-expression-of-pd-l1-determines-efficacy-of-pd-l1-pathway-blockade-mediated/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Brain Metastases and Treatment](https://scholariq.org/topics/brain-metastases-and-treatment/)

## Researcher university

- [University of Michigan](https://scholariq.org/institutions/university-of-michigan/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.